Steve Harr is the founder of Sana Biotechnology. Sana Biotechnology has raised $700M in total funding. Latest round: IPO. Based in Seattle, WA.
Steve Harr is the President and Chief Executive Officer of Sana Biotechnology, a company focused on creating and delivering engineered cells as a treatment for various disease types. Prior to co-founding Sana, he served as Chief Financial Officer and Head of Corporate Development for Juno Therapeutics until its acquisition. Sana Biotechnology secured $700 million in initial financing.
Full founder directory · Investor directory · Company funding database · Fundraising library